Fundraising Fox

Intrinsic Therapeutics

Woburn, US · Founded 2000 · Delaware corporation · 85 employees on LinkedIn · 5 known investors

Barricaid develops a bone-anchored implant designed to reduce reherniation and reoperation in patients undergoing discectomy for large annular defects. The device is marketed to physicians and patients with lumbar disc herniation.

HealthtechMedical Devices

Founders & leadership

Intrinsic Therapeutics was founded in 2000 by Gregory H. Lambrecht.

GH
Gregory H. LambrechtFounder
CH
Carey HaganExecutive
KC
Kevin ConnorsNamed on SEC filing
CH
Cary HaganNamed on SEC filing

Board

RDRyan Drant
Ryan Drantin𝕏Board directorFounder and Managing Partner at Questa Capital
JD
Jeani Delagardelle𝕏Board directorVenture Partner at New Leaf Venture Partners
JM
Joshua MakowerBoard director
BV
Brian VerrierBoard director
KS
Kevin SidowBoard director

Investors · 5

Delos CapitalCambridge
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
Questa CapitalSan Francisco · $15M – $40Mvia Ryan Drant · board
Greenspring AssociatesreportedPortland
New Leaf Venture PartnersreportedNew Yorkvia Jeani Delagardelle · board

Reported raises · per SEC filings

Form D private placements

$189.8M disclosed across 7 rounds · 2014–2023

▶$55.5MraisedDec 2023 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeani DeagardellelDirector
  • Gregory H. LambrechtDirector
  • Ryan DrantDirector
  • Cary HaganExecutive Officer, Director
  • Peter PizzoExecutive Officer
  • Brian VerrierDirector
Offering amount
$68.5M
Amount sold
$55.5M
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.5MraisedAug 2023 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin SidowDirector
  • Gregory H. LambrechtDirector
  • Ryan DrantDirector
  • Brian VerrierDirector
  • Peter PizzoExecutive Officer
  • Jeani DelagardelleDirector
  • Cary HaganExecutive Officer, Director
Offering amount
$5.5M
Amount sold
$5.5M
First sale
Jul 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.9MraisedApr 2023 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian VerrierDirector
  • Gregory LambrechtDirector
  • Kevin SidowDirector
  • Jeani DelagardelleDirector
  • Ryan DrantDirector
  • Cary HaganExecutive Officer, Director
Offering amount
$7.5M
Amount sold
$5.9M
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38.4MraisedApr 2021 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ryan DrantDirector
  • Jeani DelagardelleDirector
  • Gregory H. LambrechtDirector
  • Brian VerrierDirector
  • Joshua MakowerDirector
  • Carey HaganExecutive Officer, Director
  • Kevin SidowDirector
Offering amount
$40M
Amount sold
$38.4M
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38.8MraisedApr 2019 · 28 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ryan DrantDirector
  • Joshua MakowerDirector
  • Brian VerrierDirector
  • Kevin SidowDirector
  • Jeani DelagardelleDirector
  • Gregory H LambrechtExecutive Officer, Director
  • Cary HaganExecutive Officer, Director
  • Kevin ConnorsDirector
Offering amount
$41.7M
Amount sold
$38.8M
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$28.4MraisedMar 2017 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gregory H LambrechtExecutive Officer, Director
  • Cary HaganExecutive Officer, Director
  • Ryan DrantDirector
  • Kevin SidowDirector
  • Brian VerrierDirector
  • Jeani DelagardelleDirector
  • Kevin ConnorsDirector
  • Joshua MakowerDirector
Offering amount
$28.4M
Amount sold
$28.4M
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.3MraisedSep 2014 · 28 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin SidowDirector
  • Kevin ConnorsDirector
  • Brian VerrierDirector
  • Joshua MakowerDirector
  • Gregory H. LambrechtExecutive Officer, Director
  • Jeani DelagardelleDirector
  • Cary HaganExecutive Officer, Director
  • Ryan DrantDirector
Offering amount
$20.9M
Amount sold
$17.3M
First sale
Aug 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Intrinsic Therapeutics Announces Initial Release of Its Next Generation Barricaid Narrow Anchor Device Designed to Reduce Reherniation After Back Surgeryprnewswire.com · Mar 2026Intrinsic Therapeutics raises $52m for Barricaid annulus seal - MassDevicemassdevice.com · Apr 2019Intrinsic Therapeutics Completes $52m Financing to Fuel Commercial Efforts in the United States to Benefit Lumbar Discectomy Patientsprnewswire.com · Apr 2019Intrinsic Therapeutics Completes $52M Financing - FinSMEsfinsmes.com · Apr 2019Intrinsic Therapeutics lands $11.6M in new funding for treatment of herniated lumbar discs -orthostreams.com · Nov 2012

Frequently asked questions

What does Intrinsic Therapeutics do?
Barricaid develops a bone-anchored implant designed to reduce reherniation and reoperation in patients undergoing discectomy for large annular defects. The device is marketed to physicians and patients with lumbar disc herniation.
Who founded Intrinsic Therapeutics?
Intrinsic Therapeutics was founded by Gregory H. Lambrecht in 2000.
Who are Intrinsic Therapeutics's investors?
Intrinsic Therapeutics's investors include Delos Capital, New Enterprise Associates (NEA), Questa Capital, Greenspring Associates, New Leaf Venture Partners.
How much funding has Intrinsic Therapeutics raised?
Intrinsic Therapeutics has disclosed $189.8M raised across 7 rounds.
Where is Intrinsic Therapeutics headquartered?
Intrinsic Therapeutics is headquartered in Woburn, US.